Lamivudine for patients with chronic hepatitis B and advanced liver disease. - Wikidata - wikimedia - TriplyDB

Lamivudine for patients with chronic hepatitis B and advanced liver disease.

Lamivudine for patients with chronic hepatitis B and advanced liver disease.

http://www.wikidata.org/entity/Q34551713

about

Viral hepatitis and hepatocellular carcinoma Entecavir for chronic hepatitis B Antiviral agents for hepatitis B virus-related cirrhosis Entecavir for chronic hepatitis B Clinical features of chronic hepatitis B patients with YMDD mutation after lamivudine therapy.Pre- and Post-Transplant Antiviral Therapy (HBV, HCV)Evaluation of Antiviral Therapy Performed after Curative Therapy in Patients with HBV-Related Hepatocellular Carcinoma: An Updated Meta-Analysis The Comparative Efficacy and Safety of Entecavir and Lamivudine in Patients with HBV-Associated Acute-on-Chronic Liver Failure: A Systematic Review and Meta-Analysis KASL clinical practice guidelines: management of chronic hepatitis B Brazilian society of hepatology recommendations for the diagnosis and treatment of hepatocellular carcinoma Liver transplantation for viral hepatitis in 2015 Hepatitis B virus therapy: What's the future holding for us?Prevention and Management of Chronic Hepatitis B The Molecular and Structural Basis of HBV-resistance to Nucleos(t)ide Analogs Antiviral Therapy of Liver Cirrhosis Related to Hepatitis B Virus Infection Benefits of nucleos(t)ide analog treatments for hepatitis B virus-related cirrhosis Molecular cancer prevention: Current status and future directions Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma Current and future directions for treating hepatitis B virus infection Does antiviral therapy reduce complications of cirrhosis?Application of nucleoside analogues to liver transplant recipients with hepatitis B Nucleot(s)ide analogues for hepatitis B virus-related hepatocellular carcinoma after curative treatment: a systematic review and meta-analysis Management of chronic hepatitis B: Canadian Association for the Study of the Liver consensus guidelines The importance of baseline viral load when assessing relative efficacy in treatment-naïve HBeAg-positive chronic hepatitis B: a systematic review and network meta-analysis Direct acting antivirals for the treatment of chronic viral hepatitis Prevention of hepatocellular carcinoma in patients with chronic hepatitis B Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go?Magnetic resonance elastography of liver: technique, analysis, and clinical applications.Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B AACR Cancer Progress Report 2014 Viruses and human cancer Effects of antiviral therapy on preventing liver tumorigenesis and hepatocellular carcinoma recurrence.Surveillance for hepatocellular carcinoma.Molecular mechanism and treatment of viral hepatitis-related liver fibrosis.Prediction models of hepatocellular carcinoma development in chronic hepatitis B patients Treatment for hepatitis B in patients with drug resistance The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy Prevention of Hepatocellular Carcinoma Role of antiviral therapy in the natural history of hepatitis B virus-related chronic liver disease Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges

P2860

Q21245597-AA0E3881-B105-4E5A-9F0B-BA6E3DF6317E Q24195119-A986ED64-1D75-4218-B7C2-8E7AF84B3344 Q24200681-BBCEFDE6-E565-40F3-ACA3-EB5F1681D6B8 Q24244842-7CC79433-96CA-4B36-906C-6E6AFB48D480 Q24542846-FCD617AC-DD84-495E-8CAE-788AAF0B5B17 Q26740319-DD193ADD-EAD2-443A-9A46-BF17F93967FD Q26742104-4D9EE2D1-0279-4F49-8334-9158D783ED6E Q26752443-A8EAC7B6-057E-4A02-9CFF-84B5B624BD55 Q26752475-4C07B3AC-5A5C-486B-A1D8-70DFDEC4C412 Q26766707-3BDC551E-77E1-4BEB-9916-CCA4FC2D3FF5 Q26773224-E6083E47-BFC6-4EF8-A780-C595BE2867E3 Q26774198-1A416993-A759-4C75-8C84-E1AA91027460 Q26775726-FE3AE129-BA42-4372-BEB9-88C57E4C2196 Q26781795-F28A0ECE-466E-4E2C-8EA1-0C010FEFB18A Q26781962-99B3372A-10AB-4512-B1AC-7A852314A252 Q26783356-5C137C23-65CC-478D-AF99-513E59C01BC5 Q26797207-DE071532-B388-4EBC-A0E3-345CB6931B4A Q26799056-BCA8BED6-334F-4294-B352-A69C72ACA9A6 Q26851240-DBB6C725-7EC2-4044-94BA-DCCAF3943D47 Q26851410-042246AB-3573-4AEB-843C-51748AB0B46A Q26859796-80F76E5A-2251-4396-A2E7-6D5EF47125FE Q26998178-0454E9E6-58C8-4198-84AE-7D7E4669FAED Q27000080-C887B229-4CBD-4EA6-9476-A83FC188FBE6 Q27016075-00A91D8C-5A68-45AA-B816-168F2788B168 Q27022216-3EB08185-9A5C-45E4-92A2-842FA2CD0D9D Q27023997-3D966C0F-BAF1-4D83-AC69-1FDFF9B98809 Q27025083-2B8ACEA1-276C-4E0F-B953-DD9C8541E54A Q27027849-6079AA0F-9C5A-4427-8651-7637A5093267 Q27030828-B4B7E3E3-C900-4B84-B597-3FFD7FE4188E Q27346723-A07C3734-56FC-47D6-A2E3-2A7E1F29E0DA Q27481175-967F2E1F-6E1C-49EE-8D87-93671379E58A Q27687423-40F29531-A220-4CA6-ADDE-CCCEFDA1681C Q27690269-C7A05555-682B-4554-8470-78B3325B5CC9 Q27692609-B9702315-E1AD-4F70-A8A1-889F330D89BD Q28066959-6B63440B-165B-42CE-9700-B9F1FD2E14F2 Q28072483-C3BF7A82-E172-45DF-B7B6-79A377872DAE Q28075923-83E0CABC-3629-408E-AB15-8D9BC01B2141 Q28079576-09BE8428-F522-46CE-A746-B1BAAA5D9F12 Q28088566-258C9ABE-C45D-419F-9E70-14B53D53C1A9 Q28272678-9B4ED699-9A47-4400-B0B2-133BFE5EA304

P2860

Lamivudine for patients with chronic hepatitis B and advanced liver disease.

http://www.wikidata.org/entity/Q34551713

description

2004 nî lūn-bûn

@nan

2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Lamivudine for patients with chronic hepatitis B and advanced liver disease.

@ast

Lamivudine for patients with chronic hepatitis B and advanced liver disease.

@en

Lamivudine for patients with chronic hepatitis B and advanced liver disease.

@nl

type

label

Lamivudine for patients with chronic hepatitis B and advanced liver disease.

@ast

Lamivudine for patients with chronic hepatitis B and advanced liver disease.

@en

Lamivudine for patients with chronic hepatitis B and advanced liver disease.

@nl

prefLabel

Lamivudine for patients with chronic hepatitis B and advanced liver disease.

@ast

Lamivudine for patients with chronic hepatitis B and advanced liver disease.

@en

Lamivudine for patients with chronic hepatitis B and advanced liver disease.

@nl

P1433

Q34551713-B84861F0-410A-42FF-9EDD-B61E0D04F97A

P1476

Q34551713-D9163292-FA12-4D56-ABCD-C84C0FA160BF

P2093

Q34551713-05EB5740-007A-4344-98DA-CEA4284C6B02

Q34551713-0F10F1E9-B92E-4C6A-B252-538B296D8A36

Q34551713-3E63BEDE-FDB7-4DCF-BA19-91CA4EF349A6

Q34551713-7B588DA3-C023-47AC-B865-E22C82EAC255

Q34551713-98691707-A8AF-495A-A80B-4542BF57C28F

Q34551713-B5924797-8B14-45D3-9918-E5D8C95D5C11

Q34551713-C4D83555-AD9B-4FBA-B0AA-260D6BF8ABE6

Q34551713-CA696B30-2FE3-4BA7-9C21-E2C026B298F8

Q34551713-DAE22D64-0D6E-4D6D-BEC8-6BD1DA5FAED4

Q34551713-DBC2B6FD-DD32-4EF4-BEEF-E662D2CC26D2

P304

Q34551713-603A3443-4F1A-486E-BF1B-2DB6C4145EA3

P31

Q34551713-19DA8F1B-AF07-4F56-8BC4-82D6488F3489

P356

Q34551713-09E80A26-915C-4923-8680-689CC91BCC78

P407

Q34551713-48F86D08-6C3E-4D91-84DC-7D4F604B1E92

P433

Q34551713-DE3ADD3A-E31F-462A-B4E0-9D3DBB05DB42

P478

Q34551713-2BF988C7-FC2F-46FB-8150-2CC60186A96A

P50

Q34551713-82100002-4d19-b826-2dbd-d2d0d280c663

P577

Q34551713-2FBF0EA8-FD6D-4A81-8B25-C2F0427C98E2

P698

Q34551713-B9BE3A48-ED88-47EF-BA88-C42E7C5D9C2F

P921

Q34551713-09724DB3-E2A3-479D-AAD7-A607199F693A

Q34551713-840E16F3-A6A7-42B1-87F8-2B3004CA6158

P356

P1433

The New England Journal of Medicine

P1476

Lamivudine for patients with chronic hepatitis B and advanced liver disease.

@en

P2093

Cha-Ze Lee

http://www.w3.org/2001/XMLSchema#string

Cirrhosis Asian Lamivudine Multicentre Study Group

http://www.w3.org/2001/XMLSchema#string

D Fraser Gray

http://www.w3.org/2001/XMLSchema#string

Geoffrey Farrell

http://www.w3.org/2001/XMLSchema#string

Hon Yuen

http://www.w3.org/2001/XMLSchema#string

Jan Sabbat

http://www.w3.org/2001/XMLSchema#string

Jonathan S Dixon

http://www.w3.org/2001/XMLSchema#string

Joseph J Y Sung

http://www.w3.org/2001/XMLSchema#string

Kelly Shue

http://www.w3.org/2001/XMLSchema#string

Oliver N Keene

http://www.w3.org/2001/XMLSchema#string

P304

1521-1531

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA033364

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

351

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15470215

http://www.w3.org/2001/XMLSchema#string

P921

liver cirrhosis